Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
BioConferenceLive

Enhanced Characterization Technology Provides Better Understanding of Shape, Structure of Proteins

By BiotechDaily International staff writers
Posted on 20 Feb 2013
Image: The Viscotek TDA at Hamburg EMBL is used to enhance protein characterization by small angle X-ray scattering (SAXS) (Photo courtesy of Malvern Instruments).
Image: The Viscotek TDA at Hamburg EMBL is used to enhance protein characterization by small angle X-ray scattering (SAXS) (Photo courtesy of Malvern Instruments).
A triple detector array system used before protein analysis provides complementary biophysical data and simultaneously purifies samples for measurement, resulting in more data and better quality information from each experiment.

Researchers from the European Molecular Biology Laboratory (EMBL; Hamburg, Germany), have integrated a multidetector array size exclusion chromatography (SEC) system from Malvern Instruments (Viscotek TDA triple detector array; Malvern, Worchester, UK) at the laboratory’s strong, small angle X-ray scattering (SAXS) beamline to improve the productivity and quality of detailed protein characterization work.

This novel set-up is not only limited to the institute itself, but is widely accessible to structural biology researchers via BioStructX, a European Commission initiative that creates a single gateway to Europe’s leading synchrotron facilities.

SEC generates a fractionated sample for measurement, separated on the basis of hydrodynamic size. The Viscotek TDA integrates refractive index, ultraviolet (UV), and light scattering detectors, which in combination provide concentration and absolute molecular weight measurement for these eluting fractions. Incorporating this system with the SAXS beamline provides purified samples for measurement that provide optimal signal-to-noise ratios and high quality data. In combination with the biophysical information from the TDA, these data provide detailed evidence about the internal shape and structure of proteins that furthers understanding of their behavior. Specifically, SAXS information is helpful for the determination and tracking of the low-resolution structures and conformational alterations that proteins exhibit.

Both EMBL Hamburg and Malvern Instruments are partners in the BioStructX project, which brings together facilities from across Europe to establish a cutting-edge coordinated and multisite infrastructure to support access for key methods in structural biology. The new integrated SEC-SAXS set-up was developed by a number of specialists within EMBL, and with input from Malvern Instruments to enhance the department’s systems to BioSAXS users transnationally. The automated multipronged characterization has already demonstrated its advantages to the first users and it is expected to be in demand as the BioSructX project advances.

Malvern provides materials and biophysical characterization technology and expertise that enable scientists and engineers to determine and control the properties of dispersed systems. These systems range from proteins and polymers in solution, particle and nanoparticle suspensions, and emulsions, through to sprays and aerosols, industrial bulk powders and high concentration slurries.

Related Links:
European Molecular Biology Laboratory
Malvern Instruments


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: In the liver tissue of obese animals with type II diabetes, unhealthy, fat-filled cells are prolific (small white cells, panel A). After chronic treatment through FGF1 injections, the liver cells successfully lose fat and absorb sugar from the bloodstream (small purple cells, panel B) and more closely resemble cells of normal, non-diabetic animals (Photo courtesy of the Salk Institute for Biological Studies).

Fibroblast Growth Factor 1 Treatment Restores Glucose Control in Mouse Diabetes Model

A "vaccine" based on the metabolic regulator fibroblast growth factor 1 (FGF1) removed the insulin resistance that characterizes type II diabetes and restored the body's natural ability to manage its glucose... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Cancer Immunotherapy Sector Predicted to Surge to USD 9 Billion Across Major Pharma Through 2022

The immunotherapy market will experience substantial growth through 2022, increasing from USD 1.1 billion in 2012 to nearly USD 9 billion in 2022 (corresponding to 23.8% annual growth) in the United Kingdom, United States, France, Germany, Italy, Spain, and Japan, according to recent market research. This notable growth... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.